Contact us Media PRESS RELEASE 2021 > Ferring Pharmaceuticals announces changes to Board of Directors PRESS RELEASE 2021 01 July 2021 Ferring Pharmaceuticals announces changes to Board of Directors Frederik Paulsen steps down from his role as Chairman of the Board of Directors Lars Rebien Sørensen appointed Chairman of the Board of Directors Jean-Frédéric Paulsen appointed to the Board of Directors Saint-Prex, Switzerland – 1 July 2021 – Ferring Pharmaceuticals announced today that Frederik Paulsen is stepping down from his role as Chairman of the Board of Directors* and transitioning to the role of Honorary Chairman. Lars Rebien Sørensen is appointed Chairman of the Board of Directors. Jean-Frédéric Paulsen is also appointed to the Board of Directors. All of these changes are effective immediately. Mr. Paulsen has been Chairman of Ferring’s Board of Directors since 1988. During Mr Paulsen’s tenure, the company has delivered impressive growth and expanded rapidly into new markets, with a presence in almost 60 countries and revenues of nearly EUR 2 billion today. “My father Frederik Paulsen and stepmother Eva Paulsen founded Ferring in 1950, and it has been an honour to continue their legacy of pioneering science while driving the global expansion of the company,” said Mr Paulsen. “As Ferring enters its next phase of growth, this is the right moment for me to hand over the reins. With his extraordinary track record, I am confident that Lars will effectively guide Ferring towards its ambitious long term strategic and financial targets, while keeping alive the pioneering spirit on which the company was built.” Lars Rebien Sørensen has over three decades of general management experience in the pharmaceutical industry and was President and CEO of Novo Nordisk A/S from 2000 until 2016, spearheading the company’s growth into a highly respected and successful global pharmaceutical company. Today, Mr Sørensen is Chair of the Board of the Novo Nordisk Foundation, Chair of the Board of Novo Holdings A/S, a board member of Thermo Fischer Scientific Inc., as well as Chair of the Advisory Board of Axcel Management A/S. “I’m excited to take on the role of Chairman of the Board of Directors at Ferring Pharmaceuticals and will seek to build on the company’s strong foundations and continue its impressive track record of growth,” said Mr Sørensen. “I look forward to working with the Board of Directors and the Executive Committee, to bring the company’s long-term strategy to life and help more people around the world build families and live better lives.” Jean-Frédéric Paulsen is Chairman of Ferring Ventures SA, in addition to other activities. He previously served as Senior Advisor to four Ministers of Economy and Sustainable Development of Georgia and has worked at Mars Inc, Coca Cola and Credit Suisse. After he steps down as Chairman, Frederik Paulsen will transition to Honorary Chairman of Ferring’s Board of Directors, continuing to provide support and ensuring a smooth transition for the Board. Mr Paulsen will also dedicate more time to his passions of polar exploration and climate change science, in addition to his diverse philanthropic activities and the oversight of his other investments. * Refers to the Board of Directors of Ferring Holding S.A – the parent company of the Ferring Pharmaceuticals group About Ferring Pharmaceuticals Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs around 6,000 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. Learn more at www.ferring.com, or connect with us on Twitter, Facebook, Instagram, LinkedIn and YouTube. Press release translations Read the press release in French here. Read the press release in German here. For more information, please contact Bhavin Vaid Head of Corporate Communications +41 58 301 0952 (direct) +41 79 191 0632 (mobile) bhavin.vaid@ferring.com Lindsey Rodger Senior Manager, Corporate Communications +41 58 451 4023 (direct) +41 79 191 0486 (mobile) lindsey.rodger@ferring.com READ MORE PRESS RELEASES At Ferring, we are committed to building families worldwide and helping people live better lives. We are a leader in reproductive medicine and maternal health, gastroenterology and urology. Legal Legal disclaimer Privacy Cookies Contact us Global Locator Media enquiries Report a side effect Ferring Worldwide Select country and territory Select country and territory Albania Algeria Angola Argentina Armenia Australia Austria Azerbaijan Bahrain Belgium Bolivia Bosnia and Herzegovina Brazil Bulgaria Burkina Faso Cameroon Canada Chile China, M&S China, Manufacturing China, R&D Colombia Congo Costa Rica Croatia Cuba Czech Republic, Manufacturing Czech Republic, Marketing & Sales Denmark, IPC, Research & Development Denmark, Manufacturing Denmark, Marketing & Sales Dominican Republic Ecuador Egypt El Salvador Ethiopia Finland France Gabon Georgia Germany, Manufacturing Germany, Marketing & Sales Ghana Greece Guatemala Hong Kong Hungary India, IPC Research & Development India, Manufacturing India, Marketing & Sales Iran Iraq Ireland Israel, BTG, Manufacturing and Research & Development Israel, Marketing & Sales Italy Ivory Coast Japan Jordan Kazakhstan Kenya Korea Kosovo Kuwait Kyrgyzstan Lebanon Libya Macedonia Madagascar Malaysia Mali Mauritania Mauritius Mexico, Commercial Office Mexico, Manufacturing Middle East, Turkey & Africa Regional Office Moldovia Mongolia Montenegro Morocco Niger Nigeria Norway Oman Pakistan Panama Paraguay Peru Philippines Poland Portugal Qatar Romania Russia Saudi Arabia Senegal Serbia Singapore Slovakia Slovenia South Africa Spain Sudan Sweden Switzerland, Global Headquarters Switzerland, Marketing & Sales Switzerland, Marketing & Sales Switzerland, Research & Development Syria Taiwan Tajikistan Tanzania Thailand The Netherlands Togo Trinidad and Tobago & Carib.Islands Tunisia Turkey Turkmenistan Uganda UK Manufacturing, Research & Development UK Marketing & Sales Ukraine United Arab Emirates US, Ferring Research Institute (FRI) US, FIPCUS, Research & Development US, FPI, Marketing & Sales US, Manufacturing US, REBIOTIX INC. Manufacturing, Research & Development Uzbekistan Venezuela Vietnam, HANOI Marketing Vietnam, HCMC Marketing Yemen This global corporate website provides general information about the global Ferring Group. For information about Ferring or its products in a specific country, please select your country in the Global Locator. FERRING, the FERRING PHARMACEUTICALS logo and other Ferring product trade names are trademarks of Ferring B.V. save where indicated otherwise. ©2021 Ferring B.V. Ferring would like to use cookies to better understand your use of this website and improve your experience while navigating it. Please accept our use of cookies in accordance with our privacy policy. Accept Decline